Pharmaceutical trade group PhRMA put out a series of infographics to accompany its reports on the 771 cancer drugs in development, telling their take on the cancer therapeutics landscape. It’s actually pretty illustrative:
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.